A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer Oct. 31 ... of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through ...

Lung cancer begins with lung cells that have changed ... monitor your WBC during treatment to make sure that it doesn’t get too low. Your WBC is so important that if treatment causes it to ...

Biosciences announced the presentation of preclinical data investigating the potential of co-administration of ...

He says lung cancer is an unchecked, unregulated growth of abnormal cells that start growing and don't stop growing. Dr. Imel ...

In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

The lung cancer survival rate has improved 26% in the last five years, according to the American Lung Association’s ...

Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...